|
|
 Previous Article | Table of Contents | Next Article 
Blood, 15 March 2001, Vol. 97, No. 6, pp. 1796-1802
IMMUNOBIOLOGY
Tissue inhibitor of metalloproteinases 1 regulation of
interleukin-10 in B-cell differentiation and lymphomagenesis
Liliana Guedez,
Adnan Mansoor,
Bente Birkedal-Hansen,
Megan S. Lim,
Paula Fukushima,
David Venzon,
William G. Stetler-Stevenson, and
Maryalice Stetler-Stevenson
From the Flow Cytometry Unit and the Extracellular
Matrix Pathology Section, Laboratory of Pathology, and the
Biostatistics and Data Management Section, Division of Clinical
Sciences, National Cancer Institute, Bethesda, MD.
Tissue inhibitors of metalloproteinases (TIMPs), first described as
specific inhibitors of matrix metalloproteinases, have recently been
shown to exert growth factor activities. It was previously demonstrated
that TIMP-1 inhibits apoptosis in germinal center B cells and induces
further differentiation. Interleukin-10 (IL-10) is reported as a vital
factor for the differentiation and survival of germinal center B cells
and is also a negative prognostic factor in non-Hodgkin lymphoma (NHL).
However, the mechanism of IL-10 activity in B cells and the regulation
of its expression are not well understood. IL-10 has been shown to
up-regulate TIMP-1 in tissue macrophages, monocytes, and prostate
cancer cell lines, but IL-10 modulation of TIMP-1 in B cells and the
effect of TIMP-1 on IL-10 expression has not been previously studied. It was found that TIMP-1 expression regulates IL-10 levels in B cells
and that TIMP-1 mediates specific B-cell differentiation steps. TIMP-1
inhibition of apoptosis is not IL-10 dependent. TIMP-1 expression in
B-cell NHL correlates closely with IL-10 expression and with high
histologic grade. Thus, TIMP-1 regulates IL-10 expression in B-cell NHL
and, through the inhibition of apoptosis, appears responsible for the
negative prognosis associated with IL-10 expression in these tumors.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
W. G. Stetler-Stevenson
Tissue Inhibitors of Metalloproteinases in Cell Signaling: Metalloproteinase-Independent Biological Activities
Sci. Signal.,
July 8, 2008;
1(27):
re6 - re6.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Rama Iniguez, M. A. Dea-Ayuela, J. A. Sanchez-Brunete, J. J. Torrado, J. M. Alunda, and F. Bolas-Fernandez
Real-Time Reverse Transcription-PCR Quantification of Cytokine mRNA Expression in Golden Syrian Hamster Infected with Leishmania infantum and Treated with a New Amphotericin B Formulation.
Antimicrob. Agents Chemother.,
April 1, 2006;
50(4):
1195 - 1201.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Mendez, J. G. Valenzuela, W. Wu, and P. J. Hotez
Host Cytokine Production, Lymphoproliferation, and Antibody Responses during the Course of Ancylostoma ceylanicum Infection in the Golden Syrian Hamster
Infect. Immun.,
June 1, 2005;
73(6):
3402 - 3407.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Guedez, A. Martinez, S. Zhao, A. Vivero, S. Pittaluga, M. Stetler-Stevenson, M. Raffeld, and W. G. Stetler-Stevenson
Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors
Blood,
February 15, 2005;
105(4):
1660 - 1668.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Lai, G. Z. Rassidakis, L. J. Medeiros, L. Ramdas, A. H. Goy, C. Cutler, Y. Fujio, K. Kunisada, H. M. Amin, and F. Gilles
Signal Transducer and Activator of Transcription-3 Activation Contributes to High Tissue Inhibitor of Metalloproteinase-1 Expression in Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma
Am. J. Pathol.,
June 1, 2004;
164(6):
2251 - 2258.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-S. Rhee, R. Diaz, L. Korets, J. G. Hodgson, and L. M. Coussens
TIMP-1 Alters Susceptibility to Carcinogenesis
Cancer Res.,
February 1, 2004;
64(3):
952 - 961.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X.-W. Liu, M. M. Bernardo, R. Fridman, and H.-R. C. Kim
Tissue Inhibitor of Metalloproteinase-1 Protects Human Breast Epithelial Cells Against Intrinsic Apoptotic Cell Death via the Focal Adhesion Kinase/Phosphatidylinositol 3-Kinase and MAPK Signaling Pathway
J. Biol. Chem.,
October 10, 2003;
278(41):
40364 - 40372.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Guedez, A. J. McMarlin, D. W. Kingma, T. A. Bennett, M. Stetler-Stevenson, and W. G. Stetler-Stevenson
Tissue Inhibitor of Metalloproteinase-1 Alters the Tumorigenicity of Burkitt's Lymphoma via Divergent Effects on Tumor Growth and Angiogenesis
Am. J. Pathol.,
April 1, 2001;
158(4):
1207 - 1215.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
